Clinical Trials Directory

Trials / Unknown

UnknownNCT03793634

Evaluation of Topical Chamomile Versus Topical Triamcinolone Acetonide in Management of Oral Lichen Planus

Status
Unknown
Phase
Phase 1
Study type
Interventional
Enrollment
37 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Accepted

Summary

Using of herbal medications as topical chamomile which has antioxidant, anti-inflammatory and anticarcinogenesis effect with little side effects is the aim for the future treatment of OLP.

Detailed description

Oral lichen planus (OLP) is a chronic inflammatory T cell mediated autoimmune disease that affects skin and any mucous membrane particularly oral mucosa.The patient complains of burning sensation, pain; interference with eating, swallowing and speech leading to worsening of quality of life.Oxidative stress plays a role in pathomechanism of OLP disease. Enzymatic and non- enzymatic anti-oxidants act as a physiological guard against reactive oxygen species (ROS) and cytokine-mediated toxicity.Herbal treatment is the aim of the future therapy.Chamomile has anti-oxidant , anti-inflammatory effect and accelerate healing.

Conditions

Interventions

TypeNameDescription
DRUGtopical chamomileherbal medication which has antioxidant, anti-inflammatory and anticarcinogenesis effect

Timeline

Start date
2019-01-15
Primary completion
2019-12-01
Completion
2020-03-01
First posted
2019-01-04
Last updated
2019-01-04

Regulatory

Source: ClinicalTrials.gov record NCT03793634. Inclusion in this directory is not an endorsement.